FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23753 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Aspirin 800mg m/r tablet Aspirin only product in oral dose form
Aspirin exacerbated respiratory disease Non-steroidal anti-inflammatory drug exacerbated respiratory disease (disorder)
Aspirin extract Product containing aspirin (medicinal product)
Aspirin+papaveretum 500mg/7.71mg dispersible tablet Aspirin and papaveretum only product
Aspirin-induced asthma Non-steroidal anti-inflammatory drug exacerbated respiratory disease (disorder)
Aspirin-sensitive asthma with nasal polyps Non-steroidal anti-inflammatory drug exacerbated respiratory disease (disorder)
Assessment of knowledge of traditional therapy Assessment of knowledge of complementary therapy (procedure)
Assessment of use of traditional therapy Assessment of use of complementary therapy (procedure)
Assessment using Communication Abilities of Daily Living Second Edition Assessment using Communication Activities of Daily Living Second Edition (procedure)
Assessment using World Health Organization fracture risk assessment tool for hip fracture probability Hip fracture probability assessment using FRAX (fracture risk assessment tool)
Assessment using World Health Organization fracture risk assessment tool for osteoporotic fracture probability Osteoporotic fracture probability assessment using osteoporotic fracture risk assessment tool (procedure)
Assisted living facility patient Lives in assisted living facility (finding)
Asthma Accident and Emergency attendance since last visit Emergency asthma patient visit since last encounter (situation)
Asthma causes daytime symptoms 1 to 2 times per month Asthma causes daytime symptoms 1 to 2 times per month (finding)
Asthma causes daytime symptoms 1 to 2 times per week Asthma causes daytime symptoms 1 to 2 times per week (finding)
Asthma causes daytime symptoms most days Asthma causes daytime symptoms most days (finding)
Asthma causes night symptoms 1 to 2 times per month Asthma causes night symptoms 1 to 2 times per month (finding)
Asthma clinical management plan Asthma clinical management plan
Asthma follow-up Asthma monitoring
Asthma follow-up Asthma monitoring
Asthma follow-up Asthma monitoring
Asthma limits walking on the flat Asthma limits walking on the flat (finding)
Asthma with status asthmaticus Acute severe exacerbation of asthma (disorder)
Astringent adverse reaction Adverse reaction to drug
Astrocytoma, no International Classification of Diseases for Oncology subtype Astrocytoma
Astrovirus Family Astroviridae (organism)
Asymptomatic bacteriuria in pregnancy with postnatal complication Asymptomatic bacteriuria in pregnancy
Asymptomatic colonization of skin caused by virulent and/or therapy-resistant bacteria Asymptomatic carrier of infectious organism on skin
At increased risk due to lack of carbon monoxide detector in residence Inadequate carbon monoxide detection equipment in residence
At increased risk due to lack of fire extinguisher in residence Inadequate fire extinguishing equipment in residence (finding)
At increased risk due to lack of smoke detector in residence Inadequate smoke detection equipment in residence (finding)
At risk of unplanned pregnancy At increased risk for unplanned pregnancy (finding)
Ataxia co-occurrent and due to cerebrotendinous xanthomatosis Ataxia due to cerebrotendinous xanthomatosis
Ataxia due to acquired vitamin deficiency Acquired ataxia due to vitamin deficiency
Atherosclerosis of other specified arteries Atherosclerosis of artery
Atlantoaxial X-ray Plain X-ray of atlantoaxial joint
Atlantoaxial X-ray Plain X-ray of atlantoaxial joint
Atmospheric control NOS Respiratory therapy by atmospheric control
Atmospheric control NOS Respiratory therapy by atmospheric control
Atonic epilepsy Epilepsy
Atopic eczema/dermatitis NOS Atopic dermatitis
Atopic eczema/dermatitis NOS Atopic dermatitis
Atorvastatin calcium 10mg tablet Atorvastatin (as atorvastatin calcium) 10 mg oral tablet
Atorvastatin calcium 20mg tablet Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Atorvastatin calcium 40mg tablet Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
Atosiban 7.5mg/mL infusion concentrate 5mL vial Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Atovaquone+proguanil hydrochloride Product containing atovaquone and proguanil (medicinal product)
Atracurium besylate 100mg/10mL solution Atracurium besilate 10 mg/mL solution for injection
Atrial myxoma with lentigines Carney complex (disorder)
Atrioventricular block NOS Atrioventricular block
Atrioventricular block unspecified Atrioventricular block
Atrophic age-related macular degeneration Nonexudative age-related macular degeneration (disorder)
Atropine 2.1mg/pralidoxime 600mg single auto-injector solution Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form)
Atropine sulfate + edrophonium chloride 0.14mg/10mg injection Product containing only atropine and edrophonium (medicinal product)
Atropine sulfate 0.031% eye drops Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug)
Atropine sulfate 0.062% eye drops Atropine sulfate 620 microgram/mL eye solution
Atropine sulfate 0.1% eye drops Atropine sulfate 1 mg/mL eye solution
Atropine sulfate 0.25% eye drops Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Atropine sulfate 140mcg/edrophonium chloride 10mg injection solution vial Product containing only atropine and edrophonium (medicinal product)
Atropine sulfate 500micrograms/5mL conventional release oral solution Atropine only product in oral dose form
Atropine sulfate 500micrograms/5mL s/f solution Atropine only product in oral dose form
Attach identification bracelet to subject Attachment of identification band to extremity (procedure)
Attachment of flap graft to extremity Reconstruction of extremity using flap
Attachment of flap graft to hand Reconstruction of hand using flap (procedure)
Attachment of groin flap graft to hand Reconstruction of hand using distant groin flap (procedure)
Attachment of pedicle flap graft Reconstruction using skin flap
Attachment of pedicle flap graft Reconstruction using skin flap
Attempted suicide NOS Suicide attempt
Attempted suicide NOS Suicide attempt
Attend allowance exam NOS: [DS4] or [DS1500] Attendance allowance medical
Attend allowance exam NOS: [DS4] or [DS1500] Attendance allowance medical
Attention to cerebroventricular shunt NEC Attention to cerebroventricular shunt
Attention to component of connection from ventricle of brain NOS Attention to component of connection from ventricle of brain (procedure)
Attention to graft of organ NOC Attention to device (procedure)
Attention to hybrid total knee replacement NEC Attention to hybrid total knee replacement
Attention to microvascular repair of organ NOC Attention to anastomosis
Attention to prosthesis NOC Attention to device (procedure)
Attention to prosthesis NOC NOS Attention to device (procedure)
Attention to prosthesis NOC OS Attention to device (procedure)
Attention to prosthesis of aorta NOS Attention to prosthesis of aorta
Attention to total hip replacement NEC Attention to total hip replacement
Attention to total knee replacement NEC Attention to total knee replacement (procedure)
Atypical absence epilepsy Atypical absence seizure
Atypical antipsychotic Anti-psychotic agent (substance)
Audiant bone conductor Anchored bone-conduction hearing aid (physical object)
Augmentation of alveolar ridge NEC Augmentation of alveolar ridge
Augmentative communication Augmentative and alternative communication (regime/therapy)
Augmented betamethasone dipropionate Betamethasone dipropionate
Aunt of subject Aunt
Aurantimonas altamirensis Aureimonas altamirensis (organism)
Aureobacterium Microbacterium
Aureobacterium saperdae Microbacterium saperdae (organism)
Aureobacterium species Microbacterium
Auricular flap Flap (substance)
Auriculoocular anomaly and cleft lip syndrome Auricular abnormality, cleft lip, ocular abnormality syndrome
Author/writer/journalist NOS Author, journalist AND/OR related writer
Author/writer/journalist NOS Author, journalist AND/OR related writer
Autism and facial port-wine stain syndrome Sturge-Weber syndrome
Autistic disorder Pervasive developmental disorder (disorder)
Autistic disorder Pervasive developmental disorder (disorder)
Autogenous vascularized bone Autogenous vascularised bone

Start Previous Page 19 of 238 Next End


Reference Sets

Reference set descriptor

Back to Start